We are live on ! Find out more
LCOV

London Company of Virginia Portfolio holdings

AUM $16.2B
1-Year Est. Return 17.5%
This Fund
S&P 500
This Quarter Est. Return
+8.11%
1 Year Est. Return
+17.5%
3 Year Est. Return
+53.53%
5 Year Est. Return
+68.8%
10 Year Est. Return
+271.54%
AUM
$12.9B
AUM Growth
+$617M
Cap. Flow
-$259M
Cap. Flow %
-2.01%
Top 10 Hldgs %
32.24%
Holding
140
New
5
Increased
24
Reduced
87
Closed
4

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$145M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$69.4M
3
DE icon
Deere & Co
DE
+$30.5M
4
CTAS icon
Cintas
CTAS
+$29.7M
5
PGR icon
Progressive
PGR
+$26.5M

Sector Composition

Rank Sector Weight
1 Industrials 19.21%
2 Technology 17.49%
3 Financials 16.24%
4 Consumer Discretionary 12.24%
5 Consumer Staples 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
126
Costco
COST
$421B
$406K ﹤0.01%
1,730
NTR icon
127
Nutrien
NTR
$32.1B
$399K ﹤0.01%
6,920
AMGN icon
128
Amgen
AMGN
$225B
$314K ﹤0.01%
1,517
AFG icon
129
American Financial Group
AFG
$12B
$300K ﹤0.01%
2,700
NEE icon
130
NextEra Energy
NEE
$179B
$292K ﹤0.01%
6,980
-2,060
-23% -$87.7K
SONY icon
131
Sony
SONY
$138B
$267K ﹤0.01%
22,000
VAC icon
132
Marriott Vacations Worldwide
VAC
$4.1B
$255K ﹤0.01%
+2,284
New +$270K
LPLA icon
133
LPL Financial
LPLA
$29.7B
$248K ﹤0.01%
3,850
PEP icon
134
PepsiCo
PEP
$189B
$231K ﹤0.01%
2,066
SBUX icon
135
Starbucks
SBUX
$124B
$210K ﹤0.01%
+3,700
New +$196K
TTM
136
DELISTED
Tata Motors Limited
TTM
$199K ﹤0.01%
12,950
PETS icon
137
PetMed Express
PETS
$43M
-4,760
Closed -$210K
PPG icon
138
PPG Industries
PPG
$25.5B
-2,516
Closed -$261K
VXF icon
139
Vanguard Extended Market ETF
VXF
$32.1B
-3,463
Closed -$408K
ALXN
140
DELISTED
Alexion Pharmaceuticals
ALXN
-558,734
Closed -$69.4M

Similar funds

London Company of Virginia's Q3 2018 Portfolio in Review

As of Q3 2018, London Company of Virginia held 140 positions worth $12.9B, up 5% from $12.2B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

London Company of Virginia's Q3 2018 filing shows 5 new, 24 increased, 87 reduced and 4 closed positions. Its largest new stake was Entegris: 1,860,389 shares worth $53.9M. The largest sale was Target, an estimated $145M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

  • London Company of Virginia's largest Q3 2018 buy was Entegris: 1,860,389 shares worth $53.9M.
  • London Company of Virginia added most to Johnson & Johnson in Q3 2018, an estimated $232M increase.
  • London Company of Virginia's biggest Q3 2018 reduction was Target, cutting an estimated $145M.
  • London Company of Virginia fully exited Alexion Pharmaceuticals in Q3 2018, selling an estimated $69.4M.
  • London Company of Virginia's ten largest holdings make up 32% of its $12.9B portfolio in Q3 2018.
  • London Company of Virginia opened 5 new positions and closed 4 in Q3 2018.
  • London Company of Virginia's portfolio value rose 5% quarter-over-quarter to $12.9B.

Based on London Company of Virginia's 13F filing for Q3 2018, filed 14 Nov 2018.